Reproductive and Developmental Toxicities -- Integrating Study Results to Assess Concerns
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 23, 2011
April 23, 2020
c4a36dce-692b-4bf7-a01c-93273c8ee3e6
Related Documents
Irritable Bowel Syndrome -- Clinical Evaluation of Products for Treatment
Guidance DocumentJune 14, 2012Center for Drug Evaluation and Research
Nonclinical Evaluation of Late Radiation Toxicity of Therapeutic Radiopharmaceuticals
Guidance DocumentNovember 28, 2011Center for Drug Evaluation and Research
Time and Extent Applications for Nonprescription Drug Products
Guidance DocumentSeptember 29, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.